In today’s Pharma Pulse, the FDA expands a key biologic approval for pediatric patients, and new research highlights the success of pharmacist-led testing in rural communities.
For those managing pharmaceutical supply chains, the transition to low-carbon heat is no longer elective. Evolving regulatory frameworks, such as the European Union’s Carbon Border Adjustment ...
Ongoing conflict in the Middle East has pushed pharmaceutical companies into cold chain rerouting scrambles. Conflict in the Middle East is disrupting pharmaceutical supply chains, as the closure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results